ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
China
· Delayed Price · Currency is CNY 39.82
+1.11 (2.87%)
Apr 29, 2026, 3:04 PM CST
SHE:300723 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 191.33 | -346.46 | -540.04 | 184.61 | 290.68 | 306.92 | Upgrade
|
| Depreciation & Amortization | 214.98 | 214.98 | 198.4 | 182.2 | 97.45 | 73.47 | Upgrade
|
| Other Amortization | 17.59 | 17.59 | 29.68 | 17.92 | 16.07 | 10.95 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.16 | 1.16 | -1.27 | -0.12 | -0.19 | 0.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | 44.3 | 44.3 | 26.88 | 1.02 | 0.45 | 1.34 | Upgrade
|
| Loss (Gain) From Sale of Investments | 12.92 | 12.92 | 40.11 | 24.64 | 28.31 | -45.46 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 1.3 | 3.49 | 1.68 | 0.99 | Upgrade
|
| Other Operating Activities | -499.84 | 57.58 | 23.39 | 7.24 | 0.74 | 30.41 | Upgrade
|
| Change in Accounts Receivable | 89.69 | 89.69 | 20.93 | -12.6 | -187.23 | 76.75 | Upgrade
|
| Change in Inventory | 61.08 | 61.08 | 45.04 | -168.41 | -63.05 | -2.67 | Upgrade
|
| Change in Accounts Payable | -104.68 | -104.68 | -308.97 | 244.94 | 295.05 | -27.81 | Upgrade
|
| Change in Other Net Operating Assets | 20.58 | 20.58 | 2.44 | -10.79 | 15.81 | 13.79 | Upgrade
|
| Operating Cash Flow | 26.38 | 46.01 | -550.42 | 458.05 | 475.53 | 438.1 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -3.68% | 8.54% | 59.18% | Upgrade
|
| Capital Expenditures | -111.8 | -127.21 | -319.76 | -334.46 | -605.78 | -561.23 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.3 | 2.44 | 0.07 | 0.05 | 0.25 | 0.06 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -46.28 | Upgrade
|
| Investment in Securities | 650.32 | 8.99 | 36.75 | -353.69 | -79.76 | -340.26 | Upgrade
|
| Other Investing Activities | 492.18 | 10.58 | 7.94 | 109.11 | 15.77 | 28.13 | Upgrade
|
| Investing Cash Flow | 1,033 | -105.21 | -275 | -578.99 | -669.53 | -919.59 | Upgrade
|
| Long-Term Debt Issued | - | 2,107 | 1,970 | 1,100 | 1,200 | 1,300 | Upgrade
|
| Total Debt Issued | 1,401 | 2,107 | 1,970 | 1,100 | 1,200 | 1,300 | Upgrade
|
| Long-Term Debt Repaid | - | -1,658 | -1,079 | -1,128 | -1,332 | -317.5 | Upgrade
|
| Total Debt Repaid | -1,756 | -1,658 | -1,079 | -1,128 | -1,332 | -317.5 | Upgrade
|
| Net Debt Issued (Repaid) | -354.24 | 448.89 | 890.69 | -27.99 | -132.35 | 982.58 | Upgrade
|
| Issuance of Common Stock | - | - | 57.66 | 7.28 | - | 35.04 | Upgrade
|
| Repurchase of Common Stock | - | - | -22.37 | -0.31 | -41.65 | -123.27 | Upgrade
|
| Common Dividends Paid | -61.69 | -56.84 | -108.21 | -66.04 | -63.61 | -39.6 | Upgrade
|
| Other Financing Activities | -243.68 | -234.78 | -1.77 | 186.81 | 98.71 | -298.94 | Upgrade
|
| Financing Cash Flow | -659.61 | 157.27 | 816 | 99.76 | -138.9 | 555.81 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.74 | -0.1 | 1.31 | -2.39 | 0.1 | -0.47 | Upgrade
|
| Net Cash Flow | 399.02 | 97.98 | -8.11 | -23.57 | -332.79 | 73.84 | Upgrade
|
| Free Cash Flow | -85.41 | -81.19 | -870.18 | 123.59 | -130.25 | -123.13 | Upgrade
|
| Free Cash Flow Margin | -9.08% | -8.71% | -60.00% | 4.94% | -5.71% | -5.60% | Upgrade
|
| Free Cash Flow Per Share | -0.19 | -0.18 | -1.93 | 0.27 | -0.30 | -0.29 | Upgrade
|
| Cash Income Tax Paid | 52.1 | 46.22 | 270.13 | 353.37 | 219.43 | 280.98 | Upgrade
|
| Levered Free Cash Flow | 494.21 | -74.32 | -401.11 | 13.79 | -228.71 | -267.83 | Upgrade
|
| Unlevered Free Cash Flow | 494.21 | -74.32 | -379.17 | 37.33 | -210.61 | -243.77 | Upgrade
|
| Change in Working Capital | 43.95 | 43.95 | -328.88 | 37.05 | 40.33 | 59.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.